WebALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads*
Aleva Neurotherapeutics SA Announces MRI Approval for its …
WebDec 16, 2024 · Lausanne, Switzerland, December 16, 2024 – Aleva Neurotherapeutics, a leading developer of implants for deep brain stimulation (DBS) in major neurological … WebApr 10, 2012 · Aleva Neurotherapeutics develops next-generation neurostimulation technologies and devices for Deep Brain Stimulation (DBS) therapy. Its solutions are designed to be more versatile, more precise and more efficient than currently available DBS approaches while causing fewer side effects and complications. derby city council blue badge application
Aleva Neurotherapeutics SA Release: BRAIN Publication …
WebFeb 21, 2024 · Aleva’s revolutionary DBS system incorporates directional electrode technology that is designed to be more precise and efficient than currently available approaches, as targeted stimulation has the potential to improve therapeutic benefits while reducing side effects. WebThe Aleva directSTIM Deep Brain Stimulation System to be developed by Nuvectra is a rechargeable, 24-channel, deep brain stimulation system for the treatment of Movement Disorders (i.e. Parkinson’s Disease and/or Essential Tremor). The main devices of the Aleva directSTIM Deep Brain Stimulation System include the following: WebFeb 24, 2024 · Aleva Neurotherapeutics, a developer of implants for deep brain stimulation (DBS) in neurological indications such as Parkinson’s disease and essential tremor, has received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) study. Expand derby city council bin days